Neisseria meningitidis infection: who, when and where?

References

• Janda WM, Knapp JS. Neisseria, Moraxella catarrhalis. Manual of clinical microbiology; Washington, DC: 2003
   Google Scholar
• Apicella MA. Neisseria meningitidis. Elsevier Churchill Livingstone Publishers; Philadelphia: 2005
   Google Scholar
• Schoen C, Kischkies L, Elias J, et al. Metabolism and virulence in Neisseria meningitidis. Front Cell Infect Microbiol 2014;114(4):1-16
   Google Scholar
• Marchiafava E, Celli A. Sopra i micrococchi della meningite cerebrospinale epidemica. Gazz degli Ospedali 1884;5:59
   Google Scholar
• Weichselbaum A. Ueber die Aetiologie der akuten meningitis cerebro-spinalis. Fortschr Med 1887;5:573-83
   Google Scholar
• van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13(1):144-66
   PubMed Web of Science ®Google Scholar
• Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 2006;19(1):142-64
   PubMed Web of Science ®Google Scholar
• Davidsen T, Koomey M, Tønjum T. Microbial genome dynamics in CNS pathogenesis. Neuroscience 2007;145(4):1375-87
   PubMed Web of Science ®Google Scholar
• Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998;106(5):505-25
   PubMed Web of Science ®Google Scholar
• Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009;27(Suppl 2):B51-63
   PubMed Web of Science ®Google Scholar
• Linz B, Schenker M, Zhu P, et al. Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol 2000;36(5):1049-58
   PubMed Web of Science ®Google Scholar
• Davidsen T, Tønjum T. Meningococcal genome dynamics. Nature Rev Microbiol 2006;4(1):11-22
   PubMed Web of Science ®Google Scholar
• Borst P, Greaves DR. Programmed gene rearrangements altering gene expression. Science 1987;235(4789):658-67
   PubMed Web of Science ®Google Scholar
• Vernikos G, Medini D. Bexsero® chronicle. Pathog Glob Health 2014;108(7):305-16
   PubMed Web of Science ®Google Scholar
• Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcemia and Neisseria meningitidis. Lancet 2007;369(9580):2196-210
   PubMed Web of Science ®Google Scholar
• Harrison OB, Claus H, Jiang Y, et al. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 2013;19:566-73
   PubMed Web of Science ®Google Scholar
• Swartley JS, Marfin AA, Edupuganti S, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA 1997;94(1):271-6
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Bradley BA, Stephens DS, et al. Meningococcal Disease. N Engl J Med 2001;344(18):1378-88
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol Biol 2012;799:21-35
   PubMedGoogle Scholar
• Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol 2006;60:561-58
   PubMed Web of Science ®Google Scholar
• Yazdankhah SP, Kriz P, Tzanakaki G, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004;42:5146-53
   PubMed Web of Science ®Google Scholar
• Stephens DS. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine 2009;27(Suppl 2):B71-7
   PubMed Web of Science ®Google Scholar
• Cartwright KA, Stuart JM, Jones DM, et al. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99(3):591-601
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Pathogenesis and pathophysiology of invasive meningococcal disease. Handbook of Meningococcal Disease; Weinheim, Germany: 2006
   Google Scholar
• Trivedi K, Tang CM, Exley RM. Mechanisms of meningococcal colonisation. Trends Microbiol 2011;19(9):456-63
   PubMed Web of Science ®Google Scholar
• Pizza M, Rappuoli R. Neisseria meningitidis: pathogenesis and immunity. Curr Opin Microbiol 2015;23:68-72
   PubMed Web of Science ®Google Scholar
• Trotter CL, Gay NJ, Edmunds WJ. The natural history of meningococcal carriage and disease. Epidemiol Infect 2006;134(3):556-66
   PubMed Web of Science ®Google Scholar
• Lo H, Tang CM, Exley RM. Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis 2009;9(7):418-27
   PubMed Web of Science ®Google Scholar
• Lewis LA, Vu DM, Vasudhev S, et al. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis. M Bio 2013;4(5):e00339-13
   Google Scholar
• Brooks R, Woods CW, Benjamin DK. Jr, et al. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease. in the United States, 1994-2002. Clin Infect Dis 2006;43(1):49-54
   PubMed Web of Science ®Google Scholar
• Black S, Pizza M, Nissum M, et al. Toward a meningitis-free world. Sci Transl Med 2012;4(123):123-5
   Web of Science ®Google Scholar
• Atkinson W, Wolfe S, Hamborsky J. Centers for Disease Control and Prevention meningococcal disease. The pink book: epidemiology and prevention of vaccine-preventable diseases. 12th edition. Public Health Foundation; Washington, DC: 2011
   Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med 2001;344(18):1378-88
   PubMed Web of Science ®Google Scholar
• Smirnova I, Mann N, Dols A, et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 2003;100(10):6075-80
   PubMed Web of Science ®Google Scholar
• Lemée L, Hong E, Etienne M, et al. Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis. PLoS One 2014;9(9):e107240
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969;129(6):1327-48
   PubMed Web of Science ®Google Scholar
• Rake G, Scherp HW. Studies on meningococcal infection. III. The antigenic complex of the meningococcus–a type specific substance. J Exp Meal 1933;58:341
   PubMedGoogle Scholar
• Vermont CL, de Groot R, Hazelzet JA. Bench-to-bedside review: genetic influences on meningococcal disease. Crit Care 2002;6(1):60-5
   PubMed Web of Science ®Google Scholar
• Späth PJ, Sjöholm AG, Fredrikson GN, et al. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 1999;118(2):278-84
   PubMed Web of Science ®Google Scholar
• Fijen CA, Bredius RG, Kuijper EJ, et al. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 2000;120(2):338-45
   PubMed Web of Science ®Google Scholar
• Mayatepek E, Grauer M, Hänsch GM, et al. Deafness, complement deficiencies and immunoglobulin status in patients with meningococcal diseases due to uncommon serogroups. Pediatr Infect Dis J 1993;12(10):808-11
   PubMed Web of Science ®Google Scholar
• Fijen CA, Kuijper EJ, te Bulte MT, et al. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis 1999;28(1):98-105
   PubMed Web of Science ®Google Scholar
• Sjoholm AG, Braconier JH, Soderstrom C. Properdin deficiency in a family with fulminant meningococcal infections. Clin Exp Immunol 1982;50(2):291-7
   PubMed Web of Science ®Google Scholar
• Lear S, Eren E, Findlow J, et al. Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin. J Clin Pathol 2006;59(11):1191-3
   PubMed Web of Science ®Google Scholar
• Emonts M, Hazelzet JA, deGroot R, et al. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 2003;3(9):565-77
   PubMed Web of Science ®Google Scholar
• van Well GT, Sanders MS, Ouburg S, et al. Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS One 2012;7(5):e35837
   PubMed Web of Science ®Google Scholar
• van Well GT, Sanders MS, Ouburg S, et al. Single nucleotide polymorphisms in pathogen recognition receptor genes are associated with susceptibility to meningococcal meningitis in a pediatric cohort. PLoS One 2013;8(5):e64252
   PubMed Web of Science ®Google Scholar
• Hibberd ML, Sumiya M, Summerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999;353(9158):1049-53
   PubMed Web of Science ®Google Scholar
• Read RC, Pullin J, Gregory S, et al. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001;184(5):640-2
   PubMed Web of Science ®Google Scholar
• Faber J, Henninger N, Finn A, et al. A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease. Acta Paediatr 2009;98(3):548-52
   PubMed Web of Science ®Google Scholar
• Chauhan VS, Sterka DG, Furr SR, et al. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia 2009;57(4):414-23
   PubMed Web of Science ®Google Scholar
• Sanders MS, van Well GT, Ouburg S, et al. Toll-like receptor 9 polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors. BMC Infect Dis 2012;12:112
   PubMed Web of Science ®Google Scholar
• Sjölinder H, Mogensen TH, Kilian M, et al. Important role for Toll-like receptor 9 in host defense against meningococcal sepsis. Infect Immun 2008;76(11):5421-8
   PubMed Web of Science ®Google Scholar
• Davila S, Wright VJ, Khor CC. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 2010;42(9):772-6
   PubMed Web of Science ®Google Scholar
• Abad R, López EL, Debbag R, et al. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect 2014;142(12):2461-70
   PubMed Web of Science ®Google Scholar
• World Health Organization Working Group Control of epidemic meningococcal diseases: WHO practical guidelines Edition Foundation Marcel Merieux. Lyon, France: 1995
   Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 1999;180(6):1894-901
   PubMed Web of Science ®Google Scholar
• Cartwright KA, Stuart JM, Jones DM, et al. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99(3):591-601
   PubMed Web of Science ®Google Scholar
• Yazdankhah SP, Caugant D. Neisseria meningitidis: An overview of the carriage state. J Med Microbiol 2004;53(Pt 9):821-32
   PubMed Web of Science ®Google Scholar
• Mandal S, Wu HM, MacNeil JR, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis 2013;57(3):344-8
   PubMed Web of Science ®Google Scholar
• Aguilar-García J, Olalla-Sierra J, Perea-Milla E, et al. Analysis of the epidemiological characteristics and prognostic factors in probable or confirmed invasive meningococcal disease in a cohort of adolescents and adults during an epidemic outbreak. Rev Clin Esp 2009;209(5):221-6
   PubMed Web of Science ®Google Scholar
• Jardine A, Truman G, Sheppeard V, et al. A community outbreak of meningococcal serogroup B disease in western Sydney: the challenges of identification and significance. Commun Dis Intell Q Rep 2009;33(2):221-4
   Google Scholar
• Martínez AI, Dominguez A, Oviedo M, et al. Meningococcal Disease Working Group of Catalonia. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain). Vaccine 2009;27(25-26):3496-8
   PubMed Web of Science ®Google Scholar
• Jafri RZ, Ali A, Messonnier NE, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr 2013;11(1):17
   PubMed Web of Science ®Google Scholar
• Skoczyńska A, Waśko I, Kuch A, et al. A decade of invasive meningococcal disease surveillance in Poland. PLoS One 2013;8(8):e71943
   PubMed Web of Science ®Google Scholar
• Bijlsma MW, Bekker V, Brouwer MC, et al. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data. Lancet Infect Dis 2014;14(9):805-12
   PubMed Web of Science ®Google Scholar
• Stuart JM, Cartwright KA, Jones DM, et al. An outbreak of meningococcal disease in Stonehouse: planning and execution of a large-scale survey. Epidemiol Infect 1987;99(3):579-89
   PubMed Web of Science ®Google Scholar
• Chatt C, Gajraj R, Hawker J, et al. Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping. England 2013.Euro Surveil 2014;19(44):1-7
   Google Scholar
• Rouaud P, Perrocheau A, Taha MK, et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005. Euro Surveil 2006;11(7):178-81
   PubMedGoogle Scholar
• Elias J, Schouls LM, van de Pol I, et al. Vaccine preventability of meningococcal clone, Greater Aachen Region. Germany. Emerg Infect Dis 2010;16(3):465-72
   PubMed Web of Science ®Google Scholar
• Martin DR, Walker SJ, Baker MG, et al. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J Infect Dis 1998;177(2):497-500
   PubMed Web of Science ®Google Scholar
• Muscat M, Spiteri G, Calleja N, et al. Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007. J Med Microbiol 2009;58(Pt 11):1492-8
   PubMed Web of Science ®Google Scholar
• Jounio U, Saukkoriipi A, Bratcher HB, et al. Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland. J Clin Microbiol 2012;50(2):264-73
   PubMed Web of Science ®Google Scholar
• Azzari C, Canessa C, Lippi F, et al. Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing. Vaccine 2014;32(10):1187-91
   PubMed Web of Science ®Google Scholar
• Available from: www.simi.iss.it/files/Report_MBI.pdf
   Google Scholar
• Bechini A, Levi M, Boccalini S, et al. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany. Italy. Vaccine 2012;30(45):6396-401
   PubMed Web of Science ®Google Scholar
• Resti M, Micheli A, Moriondo M, et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin Ther 2009;31(6):1266-73
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012;30(24):3710-16
   PubMed Web of Science ®Google Scholar
• Baccarini C, Ternouth A, Wieffer H, et al. The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother 2013;9(1):162-71
   PubMed Web of Science ®Google Scholar
• Brooks R, Woods CW, Benjamin DKJr, et al. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 2006;43(1):49-54
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control & Prevention. Serogroup B meningococcal disease–Oregon, 1994. MMWR Morb Mortal Wkly Rep 1995;44(7):121-4
   Google Scholar
• Sáfadi MA, Carvalhanas TR, Paula de Lemos A, et al. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Emerg Infect Dis 2014;20(5):806-11
   PubMed Web of Science ®Google Scholar
• Gabastou JM, Agudelo CI, Brandileone MC, et al. Characterization of invasive isolates of S. pneumoniae, H. influenzae, and N. meningitidis in Latin America and the Caribbean: SIREVA II, 2000–2005. Rev Panam Salud Publica 2008;24(1):1-15
   PubMed Web of Science ®Google Scholar
• Barra GN, Araya PA, Fernandez JO, et al. Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011. PLoS One 2013;8(6):e66006
   PubMed Web of Science ®Google Scholar
• Sorhouet Pereira C, Regueira M, Mollerach M. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. J Med Microbiol 2008;57(Pt 3):338-42
   PubMed Web of Science ®Google Scholar
• Chiavetta L, Chavez E, Ruzic A, et al. Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease. Rev Argent Microbiol 2007;39(1):21-7
   PubMedGoogle Scholar
• Ines Agudelo C, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease. Colombia. Emerg Infect Dis 2008;14(6):990-1
   PubMed Web of Science ®Google Scholar
• Sosa J, Llanes R, Guzman D, et al. Typing and susceptibility to penicillin of Neisseria meningitidis isolated from patients in Cuba (1993-1999). Mem Inst Oswaldo Cruz 2001;96(4):523-5
   PubMed Web of Science ®Google Scholar
• Vyse A, Wolter JM, Chen J, et al. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect 2011;139(7):967-85
   PubMed Web of Science ®Google Scholar
• Zhang X, Shao Z, Zhu Y, et al. Genetic characteristics of serogroup A meningococci circulating in China, 1956–2005. Clin Microbiol Infect 2008;14(6):555-61
   PubMed Web of Science ®Google Scholar
• Horino T, Kato T, Sato F, et al. Meningococcemia without meningitis in Japan. Intern Med 2008;47(17):1543-7
   PubMed Web of Science ®Google Scholar
• Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 2009. Commun Dis Intell 2010;34(3):291-302
   Google Scholar
• Chiu C, Dey A, Wang H, et al. Vaccine preventable diseases in Australia, 2005 to 2007. Common Dis Intell Q Rep 2010;34:S1-167
   Google Scholar
• Baker MG, Martin DR, Kieft CE, et al. A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health 2001;37(5):S13-19
   PubMedGoogle Scholar
• O’Hallahan J, Lennon D, Oster P, et al. From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. Vaccine 2005;23(17-18):2197-201
   PubMed Web of Science ®Google Scholar
• O’Hallahan J, Lennon D, Oster P. The strategy to control New Zealand’s epidemic of group B meningococcal disease. Pediatr Infect Dis J 2004;23(12):S293-8
   Google Scholar
• Martin D, McDowell R, Sneyd E, et al. The epidemiology of meningococcal disease in New Zealand in 2002. Report prepared for the Ministry of Health by the Institute of Environmental Research Limited (ESR); Wellington, New Zealand: 2003
   Google Scholar
• Baker M, McNicholas A, Garrett N, et al. Household crowding a major risk factor for epidemic meningococcal disease in Auckland children. Pediatr Infect Dis J 2000;19(10):983-90
   PubMed Web of Science ®Google Scholar
• Loring BJ, Turner N, Petousis-Harris H. MeNZB vaccine and epidemic control: when do you stop vaccinating? Vaccine 2008;26(47):5899-904
   PubMed Web of Science ®Google Scholar
• Fazio C, Neri A, Tonino S, et al. Characterization of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008. Euro Surveill 2009;14(16):1-2
   Google Scholar
• Mastrantonio P, Stefanelli P, Fazio C, et al. Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Clin Infect Dis 2003;36(4):422-8
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Fazio C, Neri A, et al. Cluster of invasive Neisseria meningitidis infections on a cruise ship, Italy, October 2012. Euro Surveill 2012;17(50):1-2
   Google Scholar
• Stefanelli P, Fazio C, Sofia T, et al. Serogroup C meningococci in Italy in the era of conjugate menC vaccination. BMC Infect Dis 2009;9:135
   PubMed Web of Science ®Google Scholar
• Racoosin JA, Whitney CG, Conover CS, et al. Serogroup Y meningococcal disease in Chicago 1991-1997. JAMA 1998;280(24):2094-8
   PubMed Web of Science ®Google Scholar
• Jackson LA, Schuchat A, Reeves MW, et al. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995;273(5):383-9
   PubMed Web of Science ®Google Scholar
• Squires SG, Deeks SL, Tsang RS. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001. Can Commun Dis Rep 2004;30(3):17-28
   PubMedGoogle Scholar
• Tyrrell GJ, Chui L, Johnson M, et al. Edmonton Meningococcal Study Group. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg Infect Dis 2002;8(5):519-21
   PubMed Web of Science ®Google Scholar
• Chacon-Cruz E, Espinosa-De Los Monteros LE, Navarro-Alvarez S, et al. An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico. Ther Adv Vaccines 2014;2(3):71-6
   PubMedGoogle Scholar
• Barroso DE, Castiñeiras TM, Freitas FS, et al. Three outbreak-causing Neisseria meningitidis serogroup C clones, Brazil(1.). Emerg Infect Dis 2013;19(11):1847-50
   PubMed Web of Science ®Google Scholar
• Tauil Mde C, Carvalho CS, Vieira AC, et al. Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil. Braz J Infect Dis 2014;18(4):379-86
   PubMed Web of Science ®Google Scholar
• Shan X, Zhou H, Zhang J, et al. Application of multiple-locus variable number tandem repeat analysis to identify outbreak-associated neisseria meningitidis serogroup C sequence Type 4821 in China. PLoS One 2015;10(1):e0116422
   Web of Science ®Google Scholar
• Oberti J, Hoi NT, Caravano R, et al. An epidemic of meningococcal infection in Vietnam (southern provinces). Bull World Health Organ 1981;59(4):585-90
   PubMed Web of Science ®Google Scholar
• Patel MS. Australia’s century of meningococcal disease: development and the changing ecology of an accidental pathogen. Med J Aust 2007;186(3):136-41
   PubMed Web of Science ®Google Scholar
• Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012;30(Suppl 2):B26-36
   PubMed Web of Science ®Google Scholar
• Koroleva IS, Platonov AE, van Der Ende A, et al. Characteristics of pathogenic Neisseria meningitidis in Moscow: prevalence of ‘non-European’ strains. Clin Microbiol Infect 1998;4(3):123-8
   PubMedGoogle Scholar
• Souza de Morais J, Munford RS, Risi JB, et al. Epidemic disease due to serogroup C Neisseria meningitidis in Sao Paulo. Brazil. J Infect Dis 1974;129(5):568-71
   Web of Science ®Google Scholar
• de Moraes JC, Barata RB. Meningococcal disease in Sao Paulo, Brazil, in the 20th century: epidemiological characteristics. Cad Saude Publica 2005;21(5):1458-71
   PubMedGoogle Scholar
• Wang JF, Caugant DA, Li X, et al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People’s Republic of China. Infect Immun 1992;60(12):5267-82
   PubMed Web of Science ®Google Scholar
• Greenwood BM, Bradley AKJ, Smith AW, et al. Mortality from meningococcal disease during an epidemic in the Gambia, West Africa. Trans R Soc Trop Med Hyg 1987;81(4):536-8
   PubMed Web of Science ®Google Scholar
• Achtman M. Global epidemiology of meningococcal disease. Meningococcal Disease; New York: 1995
   Google Scholar
• Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 1999;93(4):341-53
   PubMed Web of Science ®Google Scholar
• Molesworth AM, Thomson MC, Connor SJ, et al. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 2002;96(3):242-9
   PubMed Web of Science ®Google Scholar
• Outbreak news. Meningococcal disease, African meningitis belt, epidemic season 2006. Wkly Epidemiol Rec 2006;81(13):119-20
   PubMedGoogle Scholar
• Xie O, Pollard AJ, Mueller JE, et al. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Vaccine 2013;31(27):2852-61
   PubMed Web of Science ®Google Scholar
• Lapeyssonnie L. La méningite cérébro-spinale en Afrique. Bull WHO 1963;28:3-114
   Google Scholar
• Greenwood BM. The epidemiology of acute bacterial meningitis in tropical Africa. Bacterial meningitis; London, UK:1987130. Riedo FX, Plikaytis BD, Broome CV. Epidemiology and prevention of meningococcal disease. Pediatr Infect Dis J 1995;14(8):643-57
   PubMed Web of Science ®Google Scholar
• Maiden MCJ, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998;95(6):3140-5
   PubMed Web of Science ®Google Scholar
• Molesworth AM, Cuevas LE, Connor SJ, et al. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis 2003;9(10):1287-93
   PubMed Web of Science ®Google Scholar
• Abio A, Neal KR, Beck CR. An epidemiological review of changes in meningococcal biology during the last 100 years. Pathog Glob Health 2013;107(7):373-80
   PubMed Web of Science ®Google Scholar
• Aguilera JF, Perrocheau A, Meffre C, et al. W135 working Group. Outbreak of the serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infects Dis 2002;8(8):761-7
   PubMed Web of Science ®Google Scholar
• Djibo S, Nicolas P, Alonso JM, et al. Outbreaks of serogroup X meningococcal meningitis in Niger 1995–2000. Trop Med Int Health 2003;8(12):1118-23
   PubMed Web of Science ®Google Scholar
• Boisier P, Nicolas P, Djibo S, et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in. 2006 in Niger. Clin Infect Dis 2007;44(5):657-63
   PubMed Web of Science ®Google Scholar
• Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis 2002;185(5):618-26
   PubMed Web of Science ®Google Scholar
• Materu S, Cox HS, Isaakidis P, et al. Serogroup X in meningococcal disease, Western Kenya. Emerg Infect Dis 13 2007;13(6):944-5
   PubMed Web of Science ®Google Scholar
• Njanpop Lafourcade BM, Tamekloe TA, Snou O, et al. Serogroup X meningococcal meningitis in Togo during 2007 and 2008 abstract P140. International Pathogenic Neisseria Conference; 7 – 12 September 2008; Rotterdam, Netherlands
   Google Scholar
• Micoli F, Romano MR, Tontini M, et al. Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A 2013;110(47):19077-82
   PubMed Web of Science ®Google Scholar
• Racoosin JA, Whitney CG, Conover C, et al. Serogroup Y meningococcal disease in Chicago. 1991-1997. JAMA 1998;280(24):2094-8
   PubMed Web of Science ®Google Scholar
• Stephens DS. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet 1999;353(9157):941-2
   PubMed Web of Science ®Google Scholar
• Vázquez JA, Abad R, Agudelo CI, et al. Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in Latin American Region. International Pathogenic Neisseria Conference; 7 – 12 September 2008; Rotterdam, Netherlands
   Google Scholar
• Fijen CAP, Kuijper EJ, Tjia HG, et al. Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis 1994;18(5):780-4
   PubMed Web of Science ®Google Scholar
• Törös B, Thulin Hedberg S, Jacobsson S, et al. Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012. Euro Surveill 2014;19(42):20940
   PubMedGoogle Scholar
• Ladhani SN, Beebeejaun K, Lucidarme J, et al. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis 2015;60(4):578-85
   PubMed Web of Science ®Google Scholar
• Trotter CL, Chandra M, Cano R, et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 2007;31(1):27-36
   PubMed Web of Science ®Google Scholar
• Popovic T, Sacchi CT, Reeves MW, et al. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis 2000;6(4):428-9
   PubMed Web of Science ®Google Scholar
• Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000;365(9248):2159
   Web of Science ®Google Scholar
• Decosas J, Koama JB. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2002;2(12):763-5
   PubMed Web of Science ®Google Scholar
• Mayer LW, Reeves MW, Al-Hamdan N, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 185 2002;185(11):1596-605
   PubMed Web of Science ®Google Scholar
• Taha MK, Parent Du Chatelet I, Schlumberger M, et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 2002;40(3):1083-4
   PubMed Web of Science ®Google Scholar
• Taha MK, Giorgini D, Ducos-Galand M, et al. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol 2004;42(9):4158-63
   PubMed Web of Science ®Google Scholar
• Kwara A, Adegbola RA, Corrah PT, et al. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitidis in West Africa. Trop Med Int Health 1998;3(9):742-6
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A, Goh KT, Barkham T, et al. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 2003;36(6):679-83
   PubMed Web of Science ®Google Scholar
• Traore Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006;43(7):817-22
   PubMed Web of Science ®Google Scholar
• Adjogble KL, Lourd M, Njanpop-Lafourcade BM, et al. The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005. Vaccine 2007;25(Suppl 1):A47-52
   PubMed Web of Science ®Google Scholar
• Guibourdenche M, Chippaux JP, Ouedraogo-Traore R, et al. Evolution of the second pandemic due to strains of Neisseria meningitidis A:4:P1.9/clone III-I. Survey in four African countries: Niger, Burkina Faso; October 1995-May 1996; Cameroon and Chad
   Google Scholar
• Rinaudo CD, Telford JL, Rappuoli R, et al. Vaccinology in the genome era. J Clin Invest 2009;119(9):2515-25
   PubMed Web of Science ®Google Scholar
• Taha MK, Deghmane AE. Meningococcal carriage: the dilemma of 4CMenB vaccine. Lancet. 2014;384(9960):2088-90
   PubMed Web of Science ®Google Scholar
• Sacchi CT, Whitney AM, Popovic T, et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992–1998. J Infect Dis 2000;182:1169-76
   PubMed Web of Science ®Google Scholar
• Nedelec J, Boucraut J, Garnier JM, et al. Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J Neuroimmunol 1990;29:49-56
   PubMed Web of Science ®Google Scholar
• Bansal V, Kumar M, Dalela M, et al. Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy. Int J Pharm 2014;471:377-84
   PubMed Web of Science ®Google Scholar
• Leca M, Bornet C, Montana M, et al. Meningococcal vaccines: Current state and future outlook. Pathol Biol 2015;63(3):144-51
   PubMed Web of Science ®Google Scholar
• Yogev R, Tan T. Meningococcal disease: the advances and challenges of meningococcal disease prevention. Hum Vaccin 2011;7:828-37
   PubMed Web of Science ®Google Scholar
• Schubert-Unkmeir A, Christodoulides M. Genome-based bacterial vaccines: current state and future outlook. BioDrugs 2013;27:419-30
   PubMed Web of Science ®Google Scholar
• Medini D, Stella M, Wassil J. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Vaccine 2015;33(23):2629-36
   PubMed Web of Science ®Google Scholar
• Vesikari T, Esposito S, Prymula R, et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013;381:825-35
   PubMed Web of Science ®Google Scholar
• Santolaya ME, O’Ryan ML, Valenzuela MT, et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 2012;379:617-24
   PubMed Web of Science ®Google Scholar
• Donnelly J, Medini D, Boccadifuoco G, et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci USA 2010;107(45):19490-5
   PubMed Web of Science ®Google Scholar
• Snape MD, Medini D, Halperin SA, et al. The challenge of post-implementation surveillance for novel meningococcal vaccines. Vaccine 2012;30:B67-72
   PubMed Web of Science ®Google Scholar
• FDA. Trumemba highlights of prescribing information 2014. Available from: www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf
   Google Scholar
• Whelan J, Bambini S, Biolchi A, et al. Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives. Expert Rev Vaccines 2015;14(5):713-36
   PubMed Web of Science ®Google Scholar